onivyde
Showing 1 - 6 of 6
Metastatic Biliary Tract Cancer Trial in Seoul (Onivyde, 5-FU/LV)
Completed
- Metastatic Biliary Tract Cancer
- Onivyde
- 5-FU/LV
-
Seoul, Korea, Republic ofAsan Medical Center
Aug 22, 2022
Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,
Recruiting
- Recurrent Solid Tumor
- +21 more
- Onivyde
- +2 more
-
Palo Alto, California
- +8 more
Jun 7, 2022
Post Marketing Surveillance Study for ONIVYDE® in South Korea
Completed
- Metastatic Pancreatic Cancer
- ONIVYDE
- +2 more
-
Daejeon, Korea, Republic of
- +9 more
Sep 27, 2021
Pancreatic Adenocarcinoma Trial in Seattle (Gemcitabine, nab paclitaxel, Onivyde)
Recruiting
- Pancreatic Adenocarcinoma
- Gemcitabine
- +4 more
-
Seattle, WashingtonVirginia mason medical Center
Jan 25, 2021
Advanced Pancreatic Cancer Trial in Worldwide (Cabiralizumab, Nab-paclitaxel, Onivyde)
Active, not recruiting
- Advanced Pancreatic Cancer
- Cabiralizumab
- +8 more
-
Phoenix, Arizona
- +40 more
Apr 6, 2022